Delivery Order SPE2DB20D3303-SPE2DB25FA2RY
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,132.68 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes valued at $7,683.48 on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a specialty immunosuppressant injection used to treat psoriasis and psoriatic arthritis, reflecting the...
- The Defense Logistics Agency awarded a $14,539.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL syringes. This order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat psoriasis and psoriatic arthritis, indicating this delivery supports...
- The Defense Logistics Agency awarded a $60,405.91 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 7, 2025, with completion scheduled for August 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a biologic immunosuppressant used to treat plaque psoriasis and other inflammatory...
- The Defense Logistics Agency awarded a $59,710.11 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with performance to be completed by July 31, 2025. This is a firm fixed price, non-competitive delivery order executed on July 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at approximately $24,948 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes. This firm fixed price contract was competitively awarded without set-aside provisions and is set to be completed by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used in the treatment of psoriasis and psoriatic arthritis,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,624.36 for TREMFYA 100 mg/mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a monoclonal antibody used to treat moderate to severe plaque psoriasis and other...
- The Defense Logistics Agency awarded a $21,765.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 12, 2025, with an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat autoimmune conditions including psoriasis and psoriatic arthritis,...
- The Defense Logistics Agency awarded a $42,749.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TREMFYA 100 mg/ml injectable medication. The order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded without set-aside provisions and carries an ultimate completion date of August 13, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...